Helsinn Healthcare & InVirtuoLabs: Collaboration in AI-driven drug discovery
Helsinn Healthcare partnered with InVirtuoLabs to apply the InVirtuoGEN generative chemistry platform to Helsinn's proprietary compound library. The collaboration aims to design and prioritize novel lead candidates for advancement into preclinical development against an undisclosed target.
Why it mattersUses InVirtuoGEN and Helsinn's compound library to speed hit-to-lead; licensing or deal terms matter to partners.
Entities Mentioned
InVirtuoLabs
People Mentioned
Gabriele Edoardo BragliaGianvito Grasso